This article is in reference from Vice. by Tim Geyer
CPharm has set aside the market for medical cannabis, focusing on flowers of varied compositions, transitioning this as an active ingredient to produce pharmaceutical products, with a more streamlined distribution network.
The company’s owner and CEO, Werner Zimmerman, claims the company has already established a presence in regions worldwide, including; Lesotho, Morroco Kazakhstan, Kyrgyzstan, North Macedonia, and Cyprus, with the project at Kazakhstan raking up a 500 million Euro investment. He plans to use Afghan territories as regions to grow cannabis, pending complete legalization in Germany.
Since the Taliban take over, this has been the first major economic deal for the country. As Europe fails to recognize the Taliban as an arm of government, which comes down to the problem; According to Steve Rolles, a senior policy analyst with the Transform drug policy foundation in the UK, “There is also the obvious concern that an injection of capital will enrich and empower the highly problematic Taliban regime—which is the reason why traditional aid donors have been very reluctant to return to Afghanistan since the allied withdrawal, despite the obvious needs of Afghani people.”
Zimmerman has claimed to have ties with the Afghani since 1991, training as an athlete in Almaty. Although his close bond with the Taliban and even acting as an international diplomat on their behalf. “The ethics and morals that prevail in Afghanistan have nothing to do with my view of humanity, but I can’t change it either,” says Zimmermann.
However, the Taliban are taking things into their hands, signing a $450 million investment with Cpharm to develop a cannabis processing plant. The Deputy Minister of Counter Narcotics and Ministry of Interior affairs are present at the investment sign-off.
Yesterday, the Deputy Minister for Counter Narcotics, Ministry of Interior Affairs met with a representative of Cpharm Company.
Cpharm will invest $450 million in setting up a hashish-processing company in Afghanistan.1/2 pic.twitter.com/4rSkdBH54U
— Ministry of Interior Affairs- Afghanistan (@moiafghanistan) November 24, 2021
The economic crackdown on the Taliban has led to sanctions on its trade. CPharm is on the losing end as Germany inches closer to complete legalization; as of November 2021, the new government reached an agreement to legalize cannabis and relax border policies concerning cannabis.
The trade deal between Cphram and the Taliban remains on pause as Zimmerman has faced death threats from the European drug cartel. His long-term friend, now minister of interior of Kyrgyzstan, has offered advice against his ambitions within the region.
However, the businessman remains hopeful times will change as the company continues to diversify, investing in Cannabis facilities worldwide.